Therapeutic plasma exchange is feasible and tolerable in severely injured patients with trauma-induced coagulopathy

• Published in: Trauma surgery & acute care open Vol. 9; no. Suppl 1; p. e001126
• Main Authors: Moore, Sarah A, Rollins-Raval, Marian A, Gillette, Jennifer M, Kiss, Joseph E, Triulzi, Darrell J, Yazer, Mark H, Paul, Jasmeet S, Leeper, Christine M, Neal, Matthew D, Raval, Jay S
• Format: Journal Article
• Language: English
• Published: England BMJ Publishing Group Ltd 01.01.2024; BMJ Publishing Group LTD; BMJ Publishing Group
• Subjects: Apheresis; blood coagulation; Blood platelets; Blood products; blood transfusion; Critical care; Injuries; Kinases; Laboratories; Mortality; multiple trauma; Original Research; Patients; Plasma; Renal replacement therapy; Thrombocytopenia; Trauma; Viscoelasticity; United States > US; blood transfusion; blood coagulation; multiple trauma
• ISSN: 2397-5776; 2397-5776
• DOI: 10.1136/tsaco-2023-001126

ObjectivesTrauma-induced coagulopathy (TIC) occurs in a subset of severely injured trauma patients. Despite having achieved surgical hemostasis, these individuals can have persistent bleeding, clotting, or both in conjunction with deranged coagulation parameters and typically require transfusion support with plasma, platelets, and/or cryoprecipitate. Due to the multifactorial nature of TIC, targeted interventions usually do not have significant clinical benefits. Therapeutic plasma exchange (TPE) is a non-specific modality of removing and replacing a patient’s plasma in a euvolemic manner that can temporarily normalize coagulation parameters and remove deleterious substances, and may be beneficial in such patients with TIC.MethodsIn a prospective case series, TPE was performed in severely injured trauma patients diagnosed with TIC and transfusion requirement. These individuals all underwent a series of at least 3 TPE procedures performed once daily with plasma as the exclusive replacement fluid. Demographic, injury, laboratory, TPE, and outcome data were collected and analyzed.ResultsIn total, 7 patients received 23 TPE procedures. All patients had marked improvements in routine coagulation parameters, platelet counts, a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13) activities, inflammatory markers including interleukin-6 concentrations, and organ system injuries after completion of their TPE treatments. All-cause mortality rates at 1 day, 7 days, and 30 days were 0%, 0%, and 43%, respectively, and all patients for whom TPE was initiated within 24 hours after injury survived to the 30-day timepoint. Surgical, critical care, and apheresis nursing personnel who were surveyed were universally positive about the utilization of TPE in this patient population. These procedures were tolerated well with the most common adverse event being laboratory-diagnosed hypocalcemia.ConclusionTPE is feasible and tolerable in severely injured trauma patients with TIC. However, many questions remain regarding the application of TPE for these critically ill patients including identification of the optimal injured population, ideal time of treatment initiation, appropriate treatment intensity, and concurrent use of adjunctive treatments.Level of evidenceLevel V.